Literature DB >> 16959581

Hypertension and diabetes: role of the renin-angiotensin system.

Karin Jandeleit-Dahm1, Mark E Cooper.   

Abstract

Hypertension is often associated clinically with diabetes as part of the insulin-resistance syndrome or as a manifestation of renal disease. Elevated systemic blood pressure accelerates micro- and macrovascular complications in diabetes. Vasoactive hormone pathways including the renin-angiotensin-aldosterone system (RAAS) appear to play a pivotal role in the pathogenesis and progression of diabetic complications and possible diabetes itself. Recent studies have increased our understanding of the complexity of the RAAS with identification of new components of this cascade including angiotensin-converting enzyme 2 and a putative renin receptor. Agents that interrupt the RAAS confer end-organ protection in diabetes via hemodynamic and non-hemodynamic mechanisms. Trials are investigating the possible role of RAAS blockade in the prevention of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959581     DOI: 10.1016/j.ecl.2006.06.007

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  16 in total

1.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 2.  A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

Authors:  Yashpal S Kanwar; Lin Sun; Ping Xie; Fu-You Liu; Sheldon Chen
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 3.  The connection between GRKs and various signaling pathways involved in diabetic nephropathy.

Authors:  Feng-Ling Wang; Li-Qin Tang; Wei Wei
Journal:  Mol Biol Rep       Date:  2012-02-21       Impact factor: 2.316

4.  Diabetic Retinopathy: Focus on Minority Populations.

Authors:  Arpine Barsegian; Boleslav Kotlyar; Justin Lee; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2017-11-11

Review 5.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

6.  A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II.

Authors:  Souad Belmadani; Juan Bernal; Chih-Chang Wei; Manuel A Pallero; Louis Dell'italia; Joanne E Murphy-Ullrich; Kathleen H Berecek
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

Review 7.  Inflammatory mechanisms of diabetic complications.

Authors:  Michael D Williams; Jerry L Nadler
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

8.  RELATIONSHIP OF OXIDATIVE STRESS TO URINARY ANGIOTENSIN CONVERTING ENZYME 2 IN TYPE 2 DIABETES MELLITUS PATIENTS.

Authors:  C I Bondor; A R Potra; C C Rusu; D Moldovan; S D Bolboacă; I M Kacso
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Apr-Jun       Impact factor: 0.877

9.  Aliskiren: An orally active renin inhibitor.

Authors:  Pranay Wal; Ankita Wal; Awani K Rai; Anuj Dixit
Journal:  J Pharm Bioallied Sci       Date:  2011-04

10.  In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides.

Authors:  Syed Aun Muhammad; Nighat Fatima
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.